Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00683839 · ClinicalTrials.gov registry record · Phase 2
Tobacco Cessation Via Public Health Dental Clinics
A Phase 2 study of Smoking, sponsored by Oregon Research Institute.
- Completed
- Registry status
- Phase 2
- Development phase
- 2,637
- Enrollment target
- 3
- Study locations
NCT00683839: Completed Phase 2 study of Smoking, sponsored by Oregon Research Institute.
NCT00683839 is a Phase 2 study of Smoking that has completed, run by Oregon Research Institute. The registered enrollment target is 2,637 participants, above the 434-participant average among 123 other Smoking trials with a reported enrollment target (508% higher). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00683839, a Phase 2 study of Smoking, has completed, sponsored by Oregon Research Institute.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 2,637 participants
- Enrollment target
- 3
- Study locations
Study Summary
The study will examine the effectiveness of public health dental practitioners using a brief office based intervention designed to help patients quit smoking or smokeless tobacco use, as compared to usual care.
Conditions Studied
Interventions
- BEHAVIORAL Brief tobacco counseling
Study Locations (3)
Mississippi
- University of Mississippi - Jackson
New York
- Columbia University - New York
Oregon
- Oregon Research Institute - Eugene
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,637 participants |
| Start Date | 2006-01 |
| Est. Completion | 2009-09 |
| Phase | Phase 2 |
What the finished NCT00683839 record still lists
NCT00683839 is an interventional study that assigns participants to a tested intervention. Its 2,637 participants enrollment target places it among the larger protocols in the corpus, above the 434-participant average among 123 other Smoking trials with a reported enrollment target (508% higher).
The record links to 1 condition, with Smoking appearing as the primary indexed condition, and to 1 intervention - of which Brief tobacco counseling is the first listed.
NCT00683839 reports a single indexed study location in Mississippi, New York, Oregon.
Frequently Asked Questions
What is clinical trial NCT00683839 about?
NCT00683839 is a clinical study titled "Tobacco Cessation Via Public Health Dental Clinics". The study will examine the effectiveness of public health dental practitioners using a brief office based intervention designed to help patients quit smoking or smokeless tobacco use, as compared to usual care.
What is the current status of trial NCT00683839?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 2,637 participants. The study started on 2006-01. Estimated completion is 2009-09.
What conditions does trial NCT00683839 study?
This clinical trial studies the following conditions: Smoking.
What interventions are being tested in trial NCT00683839?
The interventions under investigation include: Brief tobacco counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT00683839?
This trial is sponsored by Oregon Research Institute, which has 62 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00683839 being conducted?
This trial has 3 study locations across Mississippi, New York, Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00683839's enrollment target sits among peer trials
2,637 5th of 123 higher than 119 of 123 other Smoking trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Potential of Kava in Enabling Tobacco Cessation - Its Holistic Effects in Managing Stress and Insomnia Associated With Abstinence
RECRUITING · Phase 2
-
A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid Relapse
RECRUITING · Phase 2
-
App for Reducing Cravings to Smoke
RECRUITING · Phase 2
-
Reducing Tobacco-associated Lung Cancer Risk: A Randomized Clinical Trial of AB-free Kava
ACTIVE NOT RECRUITING · Phase 2
-
Proactive Health Intervention for Tobacco Users (Get PHIT)
COMPLETED · Phase 2
-
Computer-Assisted Intervention for Smoking During Pregnancy
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06455085 · 2,634 participants · NA
RESTORE: REducing Future fractureS and Improving ouTcOmes of fRagility fracturE
- NCT06825715 · 2,653 participants · NA
Multilevel Intervention for Precision Oncology
- NCT05471908 · 2,674 participants · NA
Follow-up Automatically vs. As-Needed Comparison (FAAN-C) Trial
- NCT06033950 · 2,600 participants · Phase 3
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia